29
Participants
Start Date
May 31, 2002
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Recombinant Interferon Alfa
3 million units subcutaneously every other day (Monday, Wednesday and Friday) during Days 1-19 and 29-45, for 6 1/2 weeks totaling 17 doses.
Cisplatin
30 mg/m\^2 IV over 60 minutes on days 1, 8, 15, 29, 36, 43 - weekly for total 6 doses, during 5 1/2 weeks radiation therapy.
Fluorouracil
175 mg/m\^2/day continuous infusion over 6 1/2 weeks for total 3 courses: Days 1-19 and 29-45, Days 71-108 and Days 127-168.
Radiation Therapy
External beam radiation on days 1-19 and days 29-45, 9 day treatment break on day 20.
M. D. Anderson Cancer Center at University of Texas, Houston
Collaborators (1)
National Cancer Institute (NCI)
NIH
Schering-Plough
INDUSTRY
M.D. Anderson Cancer Center
OTHER